Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guang-Yu Liu

Showing results (91-100 of 115) with videos related to

Pageof 12
Sort By:
Gland Surgery|June 14, 2016
Current status of breast reconstruction in China: an experience of 951 breast reconstructions from a single instituteNai-Si Huang, Chen-Lian Quan, Lin-Xiao-Xi Ma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2025
Efficacy and Safety of Neoadjuvant TQB2102 in Locally Advanced or Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: A Randomized, Open-Label, Multicenter, Phase II TrialJun-Jie Li, Wen-Juan Zhang, Xiao-Hua Zeng, et al.
Critical Reviews in Oncology/Hematology|January 20, 2009
Breast cancer in Chinese elderly women: pathological and clinical characteristics and factors influencing treatment patternsChuan-Dong Ma, Qin Zhou, Xiu-Qing Nie, et al.
Clinical and Translational Medicine|May 6, 2022
HSP90 N-terminal inhibitors target oncoprotein MORC2 for autophagic degradation and suppress MORC2-driven breast cancer progressionFan Yang, Rui Sun, Zeng Hou, et al.
Zhonghua Yi Xue Za Zhi|March 3, 2010
[Effect of postoperative pregnancy upon prognosis of young breast cancer patients]Jia-yi Wu, Can-ming Chen, Jia-xin Zhang, et al.
Journal of Medical Internet Research|April 21, 2025
Effectiveness of an Innovative Mobile-Based Perioperative Care Program for Women Undergoing Breast Cancer Surgery (iCareBreast): Randomized Controlled TrialYan Pang, Honggu He, Ruey-Pyng Ng, et al.
Anticancer Research|November 27, 2008
Neoadjuvant chemotherapy with vinorelbine-containing regimens in elderly patients with locally advanced breast cancerChuan-Dong Ma, Can-Ming Chen, Xiao-Song Chen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 1, 2025
CD8-guided immunochemotherapy improves pathological complete response rates in high-tumor-burden triple-negative breast cancerLi Chen, Shu-Hao Jiang, Guang-Yu Liu, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|July 15, 2009
[Study on predictors of long term results for neo-adjuvant chemotherapy in locally advanced breast cancer]Ou Huang, Can-ming Chen, Jia-yi Wu, et al.
Breast Cancer Research and Treatment|September 25, 2020
Randomized phase II clinical trial and biomarker analysis of paclitaxel plus epirubicin versus vinorelbine plus epirubicin as neoadjuvant chemotherapy in locally advanced HER2-negative breast cancer with TEKT4 variationsYi-Zhou Jiang, Li-Ping Ge, Xi Jin, et al.
Pageof 12

Showing results (91-100 of 115) with videos related to

Sort By:
Pageof 12
Gland Surgery|June 14, 2016
Current status of breast reconstruction in China: an experience of 951 breast reconstructions from a single instituteNai-Si Huang, Chen-Lian Quan, Lin-Xiao-Xi Ma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2025
Efficacy and Safety of Neoadjuvant TQB2102 in Locally Advanced or Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: A Randomized, Open-Label, Multicenter, Phase II TrialJun-Jie Li, Wen-Juan Zhang, Xiao-Hua Zeng, et al.
Critical Reviews in Oncology/Hematology|January 20, 2009
Breast cancer in Chinese elderly women: pathological and clinical characteristics and factors influencing treatment patternsChuan-Dong Ma, Qin Zhou, Xiu-Qing Nie, et al.
Clinical and Translational Medicine|May 6, 2022
HSP90 N-terminal inhibitors target oncoprotein MORC2 for autophagic degradation and suppress MORC2-driven breast cancer progressionFan Yang, Rui Sun, Zeng Hou, et al.
Zhonghua Yi Xue Za Zhi|March 3, 2010
[Effect of postoperative pregnancy upon prognosis of young breast cancer patients]Jia-yi Wu, Can-ming Chen, Jia-xin Zhang, et al.
Journal of Medical Internet Research|April 21, 2025
Effectiveness of an Innovative Mobile-Based Perioperative Care Program for Women Undergoing Breast Cancer Surgery (iCareBreast): Randomized Controlled TrialYan Pang, Honggu He, Ruey-Pyng Ng, et al.
Anticancer Research|November 27, 2008
Neoadjuvant chemotherapy with vinorelbine-containing regimens in elderly patients with locally advanced breast cancerChuan-Dong Ma, Can-Ming Chen, Xiao-Song Chen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 1, 2025
CD8-guided immunochemotherapy improves pathological complete response rates in high-tumor-burden triple-negative breast cancerLi Chen, Shu-Hao Jiang, Guang-Yu Liu, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|July 15, 2009
[Study on predictors of long term results for neo-adjuvant chemotherapy in locally advanced breast cancer]Ou Huang, Can-ming Chen, Jia-yi Wu, et al.
Breast Cancer Research and Treatment|September 25, 2020
Randomized phase II clinical trial and biomarker analysis of paclitaxel plus epirubicin versus vinorelbine plus epirubicin as neoadjuvant chemotherapy in locally advanced HER2-negative breast cancer with TEKT4 variationsYi-Zhou Jiang, Li-Ping Ge, Xi Jin, et al.
Pageof 12